Meridian Health Services Acquires Eight Clinics
On September 18, Meridian Health Services announced that it purchased eight clinics from Lutheran Health Network. The eight clinics being acquired are in Indiana: three in Bluffton, two in Peru and one each in Ossian, Warren and Markle. Lutheran Health spokeswoman Joy Lohse said the clinics currently have a combined 61 physicians, advanced practitioners and staff. Meridian Health Services is a progressive healthcare organization specializing in “whole-person” health, integrating physical, mental and social well-being. The organization has been serving the community for nearly 50 years and is accredited by the Joint Commission and certified by the Indiana Division of... Read More »
Green Clinic Forms Partnership With Allegiance Health
Green Clinic announced in September 2024 that it will be acquired by Allegiance Health Management’s CEO, Rock Bordelon, and form a partnership with the company. The partnership was announced in a Facebook post by Green Clinic on September 17, 2024. Financial terms of the deal were not disclosed. Green Clinic is a multi-specialty clinic, providing both primary and specialty care to patients of all ages, from newborns to seniors. The company has nine locations across Louisiana. Allegiance Health Management is an acute and post-acute health system based in Bossier City, Louisiana. It operates 15 hospitals in Louisiana, Texas and Mississippi, bringing extensive years of healthcare... Read More »
Telix Buys U.S. Radiopharmacy Network RLS for $230 Million
Telix Pharmaceuticals announced that it has agreed to buy RLS from its parent company, RLS Group. The acquisition of RLS will expand Telix’s North American manufacturing and distribution platform. Kirkland & Ellis acted as advisor to RLS in the transaction. RLS is America’s only Joint Commission-accredited radiopharmacy network, with 31 radiopharmacies covering more than 85% of the population. RLS’ revenue for FY 2023 was $158 million, according to the original deal press release from September 23, 2024. It is based in Miramar, Florida. Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix... Read More »
Flourish Research Receives Strategic Majority Investment from Genstar Capital
Flourish Research has announced a strategic majority investment from San Francisco, California-based Genstar Capital. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has sites throughout Alabama, California, Florida, Illinois, North Carolina, Pennsylvania and Texas. Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research. Flourish Research was formed in 2021 by New York-based private equity firm NMS Capital. Genstar Capital is a private equity investment firm that makes leveraged investments in middle-market companies. Genstar has approximately $49... Read More »
SubjectWell Buys Digital Patient Recruitment Provider Trials24
SubjectWell has announced its acquisition of Trials24, a provider of global digital patient recruitment solutions. This marks SubjectWell’s first acquisition announcement since it was acquired by New York-based private equity firm WindRose Health Investors in April 2024. Trials24 is a patient recruitment provider that assists biopharmaceutical companies and contract research organizations in completing clinical trials on time. It offers cutting-edge technology, digital marketing expertise, and an engagement center with local native-language representatives in more than 13 European countries. SubjectWell is a patient access marketplace that connects patients with chronic health conditions... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
